Lv2
198 积分 2023-07-20 加入
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era
11天前
已完结
慢性粒细胞白血病继发性骨髓纤维化71例诊治体会
1个月前
已完结
CML急变期酪氨酸酶抑制剂治疗骨髓纤维化一例并文献复习
1个月前
已完结
Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors
1个月前
已完结
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial
1个月前
已完结
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial
1个月前
已完结
Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors
2个月前
已完结
Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors
2个月前
已完结
Emerging Therapeutic Approaches for Anemia in Myelofibrosis
2个月前
已完结
皖公网安备34019202002308
